Sara Brand Associate Director Research Compliance Administration.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
Informed consent requirements
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
VA Requirements for Vulnerable Subjects Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility.
Vulnerable Populations Subpart B Requirement for IRB to make Protocol Specific Determinations.
Jeopardy Rules Game show host will divide the room into two teams When you know the answer, raise your hand and wait to be called on Your answer must.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Renewing An Approved Protocol: IRB Review Process
8 Criteria for IRB Approval of Research 45 CFR (a)
HRPP Policies & Forms Created/Revised for AAHRPP.
IRB Minutes & Records VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Ethical Principles of Human Subjects Protection
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Human Subject Research Ethics
Overview of Good Clinical Practices (GCPs)
How to Obtain Institutional Review Board (IRB) Approval Richard Wagner Associate Director UCSF Human Research Protection Program August 14, 2008.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
HRPP Training – Session Two Human Research Protection Program Manager
The Goals and Principles of Human Participant Protection Part 4: Vulnerable Populations.
AAHRPP Accreditation Karen L. Smarr, PhD Human Research Compliance Officer Truman VA Hospital, Columbia, MO Cincinnati, OH March 19, 2007.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
Research with Vulnerable Populations Marisue Cody, PhD, RN IRB Chair Training Washington DC, April 9, 2004.
Regulatory criteria for approval Bob Craig, July 2007.
The IRB Approval Process Michael Bingham, JD Assistant Director, University of Wisconsin-Madison Education IRB
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
1 Protection of Vulnerable Subjects in Research Melody Lin, Ph.D. December 2012.
How to Successfully Apply to the IRB Richard Gordin, IRB Chair True Rubal, Administrator / Director For the Protection of Human Participants in Research.
TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.
PwC Protecting the People who Volunteer to Participate in Research.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
TUN IRB: The Basics February 26, IRB Function Review human-subject research Ensure the rights & welfare of human subjects are adequately protected.
The Basics of Human Research Protections Office of Research Oversight (ORO) Veterans Health Administration Department of Veterans Affairs February 27,
Challenges of 21st Century Clinical Research from an Independent IRB’s View Chesapeake Research Review, Inc. Paul Goebel, CIP Vice President Matthew Whalen,
CUNY Human Research Protection Program (HRPP) School of Professional Studies April 18, 2013
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
OHRP’s Compliance Oversight Procedures
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
IRB Minutes Karen Jeans, MSN, CCRN, CIP COACH Program Analyst.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.
Conditional IRB Approval
What is a Data and Safety Monitoring Plan and how do I get one?
Reportable Events & Other IRB Updates February 2017
Investigator Responsibilities in Human Subjects Research
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
Additional Protections for Children Involved as Subjects in Research
Event Reporting in Human Subjects Research
Informed Consent Allison Blodgett, PhD, CIP Director of IRB Operations
Research with Human Subjects
Presentation transcript:

Sara Brand Associate Director Research Compliance Administration

Communicate recent changes in policies and procedures from recent AAHRPP re-accreditation Detailed Self-Assessment Accreditation Site Visit in December 2007 Report from Self-Assessment and Site Visit Necessitated Changes Accreditation Council meets in March 2008 to decide outcome NOTE: This is not a detailed explanation of how the changes will be implemented New policies and procedures and forms posted on website March 2008

Standard Operating Procedures Meeting Deadlines 5:00pm New Forms Request Forms for Vulnerable Populations Continuing Review Forms Noncompliance Reporting Form IND/IDE Checklists Human Subjects Research Engagement Examples and Requirements

Section III: Performance Sites III.B – List other facilities where research-related procedures will be performed (pharmacy, nursing, pathology, etc.) and ensure these entities are adequately informed Section IV: Subject Population Questions specific to each subject population removed and included on new request forms “Reasonable expectation of enrollment” Section VIII: Protection Procedures Clarification re: information the IRB wants to see if IUPUI is the lead site of a multi-site study Section IX: Data Safety Monitoring Plan Checkbox for repository/database protocols

Section X: Confidentiality & Safeguards Study Manager (data recording/collection method and measure for safeguarding information) Section XIV: Informed Consent Process Questions added re: who and how informed consent will be obtained (training, consent interview and consent document language) Checkboxes for describing steps to minimize possible coercion or undue influence Clarification re: waivers of informed consent and modifications to consent document Financial Conflict of Interest section removed Section XX: Investigational Drugs/Devices Clarification re: when IND or IDE is required

Pregnant Women, Human Fetuses and Neonates, Prisoners, and Children SOPs (+) Cognitively Impaired = Vulnerable Populations SOP

New Request Forms Prisoners, Children, Pregnant Women, Cognitively Impaired VA Requirements No research involving prisoners, pregnant women, or children unless waiver granted by the Chief R&D Officer Additional questions/requirements re: surrogate consent for incompetent individuals and individuals with impaired decision-making capacity Research Involving Children Assent/Waiver of Assent: some, all, or no children Parental Permission/Waiver of Parental Permission Policy when a child reaches the legal age of consent

Guidance re: when IND or IDE is required IND and IDE Checklists Guidance when investigator is the holder of the IND or IDE (i.e. sponsor) Formal face-to-face presentation Eventual on-line presentation Validation of IND or IDE Number Sponsor protocol; or Communication from FDA

Regulations Unanticipated Problems (45 CFR (b)(5) & 21 CFR (b)) Adverse Events (21 CFR & 21 CFR 812.3) Guidance OHRP (Jan ) FDA (Apr 2007) – Draft For more info… OHRP Guidance: FDA Guidance:

IUPUI/Clarian Policy for Prompt Reporting of UPs Adverse Events: Unexpected, related, greater risk of harm, revision to protocol/IC Other UPs: Major Protocol Deviations, Suspensions or Holds Report on Prompt Reporting Form Report within (5) business days (both internal and external) If IRB determines internal event represents UP, report to federal agencies (OHRP, FDA) and other entities, as applicable

IUPUI/Clarian Policy on Prompt Reporting of Noncompliance Report all noncompliance Report on Noncompliance Reporting Form Report with (5) business days If IRB determines noncompliance to be serious or continuing, report to federal agencies (OHRP, FDA) and other entities, as applicable

Continuing Review Study not reviewed by expiration date….automatically suspended List of subjects given to IRB and COS at VA to determine if research can continue on current subjects Determine Level of Risk Based on level of risk, IRB determines when patient medical records should be flagged re: participation in research Minutes will reflect this decision Enrollment of Non-Veterans Justification Regulations pertaining to veterans in research also pertain to non-veterans enrolled in VA research

Waiver of Consent for Planned Emergency Research is prohibited at the VA Waiver of Authorization/Informed Consent for Recruitment Office of Research Oversight (ORO) Guidance (10/09/2007) Accessing patient records for recruitment into research requires the IRB to approve waivers of authorization and informed consent for recruitment (even when accessing own patients’ records

Questions?